Colorectal Cancer Trial, Recruiting NCT07112690 Sponsor: Emory University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07112690
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with localised anal cancer or perianal skin cancer (cancer of the skin around the anus), and who have either started or are about to start chemotherapy and radiation treatment for their cancer
  • People who are regularly reporting pain levels of 5 or higher (on a standard pain scale), or who are experiencing significant pain-related interference with daily life or emotional distress
  • People aged 18 years or older
  • People who are reasonably active and able to care for themselves, with only limited inability to carry out physical work (confirm with trial site for exact fitness level requirements)
  • People with a life expectancy of more than 12 months
  • People who are able to understand the study and are willing to sign a consent form
  • Men and women of any race or ethnic background are eligible for this trial
  • People who are willing and able to complete study questionnaires
  • People who have had a previous cancer diagnosis, such as colon cancer or a previously removed anal cancer, may still be eligible
  • People living with HIV or who have a weakened immune system may still be eligible

Who may not be able to join:

  • People whose blood test shows a very low level of infection-fighting white blood cells (called neutrophils), specifically a count below 1,500
  • People whose blood test shows a very low platelet count (the cells that help blood clot), specifically a count below 80,000

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jolinta Y. Lin, MD, Emory University Hospital/Winship Cancer Institute

Phone: 404-778-1900

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 November 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Frequency of treatment breaks; Change in pain scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov